Open Access

A study on β-defensin-2 and histatin-5 as a diagnostic marker of early childhood caries progression

  • Anna Jurczak1,
  • Dorota Kościelniak1,
  • Monika Papież2,
  • Palina Vyhouskaya3 and
  • Wirginia Krzyściak3Email author
Biological Research201548:61

DOI: 10.1186/s40659-015-0050-7

Received: 7 September 2015

Accepted: 19 October 2015

Published: 31 October 2015

Abstract

Background

Recently, a continuous growth of interest has been observed in antimicrobial peptides (AMPs) in the light of an alarming increase in resistance of bacteria and fungi against antibiotics. AMPs are used as biomarkers in diagnosis and monitoring of oral cavity pathologies. Therefore, the determination of specific protein profiles in children diagnosed with early childhood caries (ECC) might be a basis for effective screening tests and specialized examinations which may enable progression of disease.

Methods

The objective of the studies was to determine the role of histatin-5 and β-defensing-2 as a diagnostic marker of early childhood caries progression. In this work, results of concentration determination of two salivary proteins (histatin-5 and β-defensin-2) were presented. In addition, bacterial profiles from dental plaque in various stages of ECC and control were marked. The assessment of alteration in the concentration of these two proteins in a study group of children with various stages of ECC and a control group consisting of children with no symptoms was performed by enzyme-linked immunosorbent assays.

Results

The statistical analysis showed a significant increase in the concentration of histatin-5 and β-defensin-2 in the study group compared to the control group and correlated with the progression of the disease.

Conclusions

The confirmation of concentration changes in these proteins during the progression of dental caries may discover valuable disease progression biomarkers.

Keywords

β-defensin-2 Histatin-5 Early childhood caries

Background

Interest for saliva as a study material is a consequence of the search for body fluid obtaining of which is easy, non-invasive, and relatively inexpensive [1, 2]. It is also possible to determine salivary proteins occurring in small concentrations. Salivary peptides have been used in monitoring pathological conditions such as oral cavity, larynx and breast cancers [3], systemic sclerosis, Sjögren’s syndrome, cirrhosis, and mucoviscidosis [4]. Currently, saliva analysis is also used in detecting infectious diseases [5].

Histatins (HST) and defensins are antibacterial proteins of the oral cavity, and their biological activity is directed toward the protection against infectious diseases, including dental caries. The development of caries is a consequence of imbalance of a natural equilibrium ensured by inborn defense systems. Periodical physiological changes of concentrations of the mentioned proteins aim at restoring ecological balance in the oral cavity.

It seems that these proteins may be involved in preventing numerous diseases such as dental caries, and because these proteins naturally occur in the oral cavity they should be clinically well tolerated.

Defensins

The role of defensins is still not yet entirely understood. Saliva contains both α-defensins and β-defensins. Alpha-defensins (HNP-1,2,3) are secreted by neutrophils, whereas β-defensins (HBD-1,2) undergo a specific expression in salivary duct cells, not in salivary gland vesicles. The increase of the number of neutrophils in blood affects an increase in α-defensin concentration in saliva [6]. A temporary, increased level of α-defensins is related to, i.e. acute inflammation, fever, poisoning, hemorrhage, quickly developing malignant tumor [7].

They have local effect—protect salivary glands against bacterial invasion (Gram-negative: P. aeruginosa, E. coli; Gram-positive: S. aureus, S. pneumoniae, S. faecalis), viruses (HIV-1, HSV-1, HAdV), and fungi (C. albicans).

β-Defensins in vitro exhibit cytotoxic activity against different eukaryotic and tumor cells [810]. In physiologic in vitro concentrations, HBD stimulate the proliferation of these cells, while in higher concentrations they are cytotoxic to them [11]. β-Defensins also participate in specific immune response as chemotactic factors—they adhere to CCR6 chemokine receptor on dendritic cells [12].

The expression of β-defensin-2 (HBD-2) is induced by proinflammatory cytokines (IL-1β, IFN-γ, TNF-α) in complex signaling pathway [1315] activated by the effect of LPS lipopolysaccharide on epithelial cells depending on mitogen-activated protein kinases (MAPK) (Fig. 1) [15].
Fig. 1

Signaling pathways in inducible expression of HBD-2 in epithelial cell. (ERK extracellular-signal-regulated kinase, hBD-2 human β-defensin-2, IκBα nuclear factor of κ light polypeptide gene enhancer in B-cell inhibitor, alpha, IKK IκB kinase, IL 1a interleukin 1a, JNK c-Jun N-terminal kinase, LBP lipopolysaccharide binding protein, LPS lipopolysaccharide, TLR toll-like receptor, MEK mitogen-activated protein kinase, NFκB nuclear factor κ-light-chain-enhancer of activated B cells, Raf proto-oncogene serine/threonine-protein kinase, sCD14 soluble CD14, Src proto-oncogene tyrosine-protein kinase Src)

Histatins

Histatins (HST)—produced in parotid and sublingual salivary glands—are among the main natural antimicrobial proteins of saliva. Among the 12 main forms of proteins occurring in saliva are HST-1, -3 and -5. HST-1 and -3 are the products of different genes, and HST-2 is formed as an effect of post-translational HST-1 modification. The remaining types are formed from HST-3 transitions or HST-5 and -6 degradation. HST-1, -3, and -5 constitute 85 % of the total content of these proteins in saliva, and HST-3 and -5 have the strongest antimicrobial activity. HST-1, -3, and -5 also constitute components of the acquired enamel pellicle (AEP).

HST destabilize cellular membrane of bacteria by assimilating with its surface leading to cell damage. Moreover, HST decrease outflow of proinflammatory cytokines (interleukins, TNFα, metabolites of arachidonic and other acids) as a response of organism to stimulation of cell walls of Gram-negative bacteria with lipopolysaccharide [16]. A range of antibacterial effect includes microbes such as S. mutans, S. aureus, P. gingivalis, E. coli, and others [17, 18].

HST-5 was demonstrated as the only protein from the HST group exhibiting antiviral activity (against HIV-1—inhibition of replication by the active domain of HST-5—Dh-5) [19, 20] (Fig. 2).
Fig. 2

Signaling pathways in inducible expression of HST in epithelial cell. (AEP acquired enamel pellicle, LPS lipopolysaccharide, MAPK mitogen-activated protein kinase, MMP matrix metalloproteinases, ROS reactive oxygen species) [24]. In the mechanism depending on protein kinases (MAPK), HST specifically assimilate with membrane receptors via a series of mechanisms inducing the production of reactive oxygen species (ROS) [25]. HST by a way of non-lytic outflow from cell lead to the release of ATP and inhibition of the main metabolic pathways (i.e. cellular respiration) [26]. Together with reactive oxygen species, HST release histamine from mast cells [27] and lead to DNA damage [28]. HST have a function of chelating transition metal ions (Cu2+ and Zn2+), which may be of importance for the protection of tooth enamel and antimicrobial protection

Among other HST functions known is their activity as inhibitors of proteolytic enzymes originating from microbes (metalloproteases, trypsin-like enzymes, cysteine proteases) or host (collagenases) [18, 21]. Especially important is the inhibition of collagenases (MMP) activity of which increases under pathological conditions and is related to inflammatory and degenerative diseases and carcinogenic processes. Currently, HST are considered to be one of the dominant substances of saliva participating in wound healing [22]. HST acting synergistically with epidermal growth factor (EGF) activate G protein-coupled receptors, which in consequence lead to growth and migration of cells (Fig. 2) [23].

The objective of this study was an attempt to use the determination of salivary proteins: HST-5 and β-defensin-2 as markers of dental caries progression at various stages of its development.

Methods

Subject of the study

The study was conducted between 2010 and 2013 and included 82 pediatric patients from the Department of Pediatric Dentistry, Institute of Dentistry, Jagiellonian University, Medical College in Krakow, Lesser Poland Małopolska province. The study included strains isolated from patients (n = 41; average age = 5 ± 2.3) diagnosed with ECC in deciduous teeth. Patients were divided in two groups: the mild group (1–2 in ICDAS II codes; n = 17) with the initial demineralization involvement (white spots/non-cavitated lesion) and severe group (with cavitated lesion) which was considered to be ≥3 in ICDAS II codes (n = 24). The control group was formed of strains isolated from children (n = 41; average age = 5 ± 1.5) without caries lesions in deciduous teeth, who were kept under the clinic’s control (Table 1). In a clinical evaluation of the patients, the presence of tooth decay in deciduous and permanent teeth, number of teeth removed due to caries, and filled teeth were assessed. The study describing the indexes of caries, dmf/DMF and the frequency, was conducted in accordance with the criteria established by the World Health Organization (1997) for epidemiological studies (Oral Health Surveys Basic Data) in artificial lighting using a dental mirror and probe.
Table 1

Salivary HST-5 and β-defensin-2 levels in early childhood caries and controls

 

Healthy control (n = 41)

Early childhood caries (n = 41)

p*

Mean (ng/ml)

SD

Mean (ng/ml)

SD

HST-5

15.29

1.16

50.75

2.11

0.0002

β-defensin-2

2.15

0.07

2.29

0.05

0.0417

t Test was used in the analysis

The classification of patients for the study was performed during a routine dental examination. This examination was conducted by a qualified dentist (internal examiner), with many years of experience in epidemiological studies of the oral cavity. Kappa coefficient was set at 0.91 in the pilot studies, which indicates the internal examiner’s reliability. The legal guardians of the participants of the study were fully informed about its aim and course and agreed on their children’s participation. The factors excluding from participation in the study were insufficiently developed chewing activity observed in small children and mentally disabled patients, and the lack of an agreement from legal guardians for their children’s participation in the experiment.

Material collection

Saliva and plaque samples were obtained from children with caries and also from children with no caries symptoms. After the classification of the patients for the research, scrapings from carious foci (in the case of children with caries) or from dental plaque (in children without caries) were collected for the examination using an open system composed of a sterile cotton swab placed in a test tube. Unstimulated saliva samples (2 ml) were collected into sterile plastic tubes in the morning before tooth-brushing and any clinical examination. Saliva samples were homogenized and clarified by centrifugation at 10,000×g for 15 min at 4 °C. The aliquots of clarified supernatants were kept at −70 °C until needed for the measurements.

The patients maintained a fasting status, and sampling was performed between 8 and 10 am after the prior oral cavity rinsing with distilled water. The collected material was sealed in sterile test tubes, inhibiting oxygen access, and transported at room temperature to the laboratory within a time period of no longer than 1 h. Saliva samples were centrifuged at 1500×g for 10 min; supernatants were collected and stored at −20 °C. Then, salivary β-defensin-2 and HST-5 levels were measured by ELISA (BIO-RAD, Hercules, CA, USA).

Bacterial culture of collected material on HLR-S medium

The material was inoculated on a selective medium (HLR-S) in the laboratory. The range of inhibition of the growth of bacteria colonizing an oral cavity was verified in a preliminary study on four media, which are described in the literature as selective for this kind of pathogens [29, 30]. The results are presented in our previous manuscript [28].

Bacterial identification

Enzymatic typing was performed based on the enzymatic profiles obtained from the STREPTOtest 24 test (Lachema, Pliva) described in our previous manuscript [28].

Salivary β-defensin-2, HST-5, and the determination of total protein concentration

The concentration of chosen antimicrobial peptides was determined by the competitive enzyme-linked immunosorbent assay (ELISA). About 50 μl of standard β-defensin-2, HST-5, or diluted saliva sample (saliva was diluted to 1:100 dilution by adding 4 μl of saliva to 400 μl of phosphate buffered saline), 50 µl of enzyme (horseradish peroxidase)-labeled antigen, and 50 µl of anti-β-defensin-2, anti-HST-5 monoclonal antibodies (1:800) were added to the secondary antibody-coated 96-well microliter plates and reacted at room temperature for 30 min. Then, the solution was decanted, and 300 µl of washing solution was added to each well and also decanted; this procedure was repeated three times. Then, 100 µl of o-phenylenediamine (OPD) solution was added. After the enzyme reaction at room temperature for 15 min, the reaction was stopped by adding 100 µl of 0.25 mol l−1 sulfuric acid. A standard curve was performed with each assay using HBD-2 and HST-5 at concentrations of 0.02, 0.05, 0.1, 0.5, 1, and 2 µg. Briefly, the wells of high-binding 96-well microliter plates (Corning Incorporated, Big Flats, NY, USA) were coated with 50 µl of each β-defensin-2, HST-5 concentration, or TBS in the control wells. The optical density (OD) was measured at 450 nm [29], and the examined protein concentration in saliva was expressed as microgram per 1 ml saliva (µg ml)−1. Salivary protein level was measured by using a standard protein assay kit (BIO-RAD, Hercules, CA, USA) with bovine serum albumin as a standard. Three samples were collected from each patient on three different occasions under same conditions. The experiments were performed in duplicates in all three occasions.

Statistical analysis

The mean values were compared using the unpaired t test and one-way ANOVA with Scheffe’s multiple comparison test, respectively. Linear regression analysis was used to evaluate the simple correlation between examined protein level and Streptococcus mutans/Lactobacillus rhamnosus/Streptococcus sanguinis/Streptococcus mitis CFU counts. Multiple linear regression analysis was performed to determine the independent contribution of explanatory variables to bacterial strain CFU counts using age, sex, β-defensin-2, and HST-5 concentration.

Results

Salivary HST-5 and β-defensin-2 levels in patients with ECC (50.75 ± 2.11; 2.29 ± 0.05 ng/ml, respectively) were significantly increased compared with control (healthy subject) (15.29 ± 1.16; 2.15 ± 0.07 ng/ml, respectively) (p < 0.001, and 0.04, respectively; Table 1).

When the results were analyzed according to the caries severity score, salivary HST-5 and β-defensin-2 levels were significantly higher in severe group (cavitated lesion) which was considered to be ≥3 in ICDAS II codes (53.06 and 2.30 ng/ml, respectively) compared to the mild group (1–2 in ICDAS II codes) with the initial demineralization involvement (white spots/non-cavitated lesion) (44.53 and 2.22 ng/ml, respectively) (p = 0.030 and p = 0.021, respectively).

Cariogenic profile was the only bacterial species recovered in severe and mild group of patients.

Noticeable is the high proportion of S. mutans and L. rhamnosus with severe group in relation to mild and control groups. Bacterial cultures demonstrated significant differences in Streptococcus mutans/Lactobacillus rhamnosus/Streptococcus sanguinis/Streptococcus mitis profiles between the severe group (dentine damage), the mild group (white spots), and control group (p = 0.04, Fig. 3).
Fig. 3

Cariogenic profile in early childhood caries between the severe, the mild, and control groups

Alternatively, ELISA results demonstrated a significant growth in HST-5 (p = 0.03) and β-defensin-2 (p = 0.04) concentrations in the saliva of the severe group compared with the mild group, where HST-5 levels in the mild population ranged between 40.11 and 45.23 ng/ml (average 42.55 ± 0.36 ng/ml) and in severe group (dentine damage) between 49.37 and 51.86 ng/ml (average 50.55 ± 0.50 ng/ml) (Table 2).
Table 2

Salivary HST-5 and β-defensin-2 levels in severe and mild groups of patients

 

The severe group (n = 24)

The mild group (n = 17)

p*

Mean (ng/ml)

SD

Mean (ng/ml)

SD

HST-5

50.55

0.50

42.55

0.36

0.03

β-defensin-2

2.22

0.19

1.74

0.21

0.04

No correlation was observed between HST-5, β-defensin-2 levels, and age, gender, social habits, diets, medications or any other co-founding factors (not published results)

Discussion

Dental caries is an infectious disease and is one of the most common diseases among children and teenagers in the world [30]. Despite numerous studies on etiology and development of the disease, scientists still do not agree on some of its aspects. Until recently, S. mutans, which has the ability to form biofilm in the oral cavity, was considered to be the main etiological factor of caries [31, 32]. The one which is currently prevailing is the opinion on complex bacterial component of caries etiology. This process, apart from S. mutans, involves several other key bacterial species, i.e.: S. sobrinus, Lactobacillus acidophilus, and Actinomyces viscosus [3337].

The objective of the study was to determine the levels of HST-5, β-defensin-2 and to compare them with bacterial profiles depending on caries progression. The obtained results demonstrated significantly higher HST-5 and β-defensin-2 levels in saliva of children with severe ECC compared to patients with the initial demineralization involvement (white spots/non-cavitated lesion).

The obtained results are consistent with the results of Gornowicz et al., who demonstrated increased level of HST-5 in group of children with severe caries, but higher concentrations were observed in children with severe form of the disease compared to patients with the initial demineralization involvement [38].

Increased activity of HST-5 was observed in wide pH range. However, in low pH (with presence of caries dental changes) protonation of histidine residues occurs, additionally increasing the antimicrobial force [18, 39]. Not only the primary form of HST-5 but also its synthetic equivalent, P-113 peptide, maintains their biological potential. Due to the proteolytic degradation of HST-5 in the oral cavity, P-113 exhibits significantly greater effectiveness toward cariogenic strains of S. mutans. This peptide penetrates into the cellular cytoplasm without disturbing the cell membrane integrity and has a significant affinity to microbial DNA [4042].

Considering the relationship of β-defensin-2 (HBD-2) to caries, Ribeiro et al., Tao et al., and Dale et al. obtained the results that were inconsistent with the results presented in this study [4345]. According to these authors, HBD-2 does not correlate with the occurrence of caries which is in contrast with HBD-1 and HNP-3 (α-defensin-3).

Also, Phattarataratip and coworkers did not demonstrate the relationship of HBD-2 with the symptoms of the disease; however, a trend in the increase of defensin level together with the increase of total content of bacteria from the mutans streptococci group was observed. Strains of S. mutans isolated from persons with caries had greater resistance to β-defensin-2 compared to strains isolated from control group [46].

It is generally known that HBD-2 exhibits the greatest activity toward Gram-negative bacteria and to a lower level toward Gram-positive bacteria. Cariogenic species, which are the most sensitive to their activity, are S. mutans and S. sobrinus [47], although HBD-2 are, compared to other salivary proteins, for instance, cathelicidin (LL37) significantly more specific toward S. mutans, which was corroborated by the results obtained in other studies [48].

This study demonstrated that the amount of specific salivary proteins of the host may influence colonization of each species of bacteria, including S. mutans and also that domination of strains considered to be more cariogenic, such as S. mutans is closely linked to the level of caries advancement (severe and moderate caries) which is reflected in increased level of selected salivary proteins of the host, both HST-5 and β-defensin-2.

When searching for the relation between the levels of HST-5 and β-defensin-2 and the number of cariogenic species of bacteria, the occurrence of specific bacterial profiles depending on the levels of the determined proteins was noticed. These data correlated with clinical data on caries severity. A recent study evaluating population of oral cavity microbes in children 3–12 years of age suggests that teeth microflora is related to an entire ecosystem of species of bacteria that it is made up of and not only a small portion related to a small number of selected, specific pathogenic species of bacteria, which together determine caries development [49, 50]. The results which were obtained from the group of children with mild caries often being described as white spots (Streptococcus mutans/Lactobacillus rhamnosus/Streptococcus sanguinis/Streptococcus mitis 9 %–4 %–56 %–31 %) are consistent with results of Aas et al. [51] and van Houte et al., who demonstrated that 10 % of children and teenagers with caries (2–21 years of age) do not have S. mutans at all. The participation of other bacterial species in the development and progression of dental caries is suggested, such as Lactobacillus, Veillonella, Bifidobacterium, Propionibacterium, acidogenic species independent of Streptococcus mutans (i.e.: S. gordonii, S. oralis, S. mitis, S. anginosus) [52], Actinomyces, and Atopobium, which was confirmed in this study. In the case of the group of the so-called white spots, the participation of S. mutans was higher compared to the control group (9 % white spot >2 % control), which was confirmed in the study by van Houte et al. in which S. mutans constituted 0.001 to 10 % [53]. Species of Streptococcus (apart from S. mutans) and Actinomyces are considered the main culprits of enamel damage. In the case of S. mutans and Lactobacillus absence, the initial demineralization of enamel may be induced by early colonizers (S. sanguinis, S. mitis, and S. oralis), which was also presented in this study, where Streptococcus sanguinis constituted 56 % in children of the white spot group.

In children from severe group participation of S. mutans amounted to 33 %, which is consistent with the results of Gross et al. [54] and Sampaio-Maia and Monteiro-Silva [55] in which in dentine damage, the participation of S. mutans amounted to approximately 30 % of total microflora. S. mutans was not a dominant species in the advanced stage of caries, where Lactobacillus, Bifidobacterium, and Prevotella dominated. Virulence of populations of cariogenic bacteria correlates with the accepted phenotype for a given environment related to bacteria acidogenic potential which may induce changes of the environment leading to the development of dental caries.

Under physiological conditions, the oral cavity of children compared to adult persons has higher percentage of bacteria belonging to phyla: Firmicutes (genera Streptococcus, Veillonella, Lactobacillus, and Granulicatella) and Actinobacteria (genera Rothia and Actinomyces) and lower percentage of bacteria from phyla Bacteroidetes (genera Bacteroidales and Prevotella), Fusobacteria (genus Fusobacterium), Spirochaetes, and TM7 strain [56]. Interestingly, percentage of cariogenic bacteria increases with the age of children. This change consists in a shift from populations of aerobic bacteria or facultative Gram-positive cocci to relatively anaerobic Gram-negative bacteria [50]. In this study, in the control group, non-pathogenic species dominated (Streptococcus mutans/Lactobacillus rhamnosus/Streptococcus sanguinis/Streptococcus mitis 2 %–5 %–22 %–15 %–56 % other species), which confirms the hypothesis on environment-dependent bacterial profile.

This study indicates great opportunities of using HST-5 in combination with β-defensin-2 in dentistry. If the potential of antibacterial peptides is to be utilized as prospective biomarkers of various diseases, including development and progression of dental caries together with proper hygiene of the oral cavity, patient education and professional prevention measures, a new approach will be created, leading to improved prevention, diagnostics, and dental caries treatment.

Antimicrobial peptides, to which mentioned proteins belong, have numerous favorable characteristics such as wide range of activity, quick antibacterial effect, competitiveness toward traditional antibiotics, thanks to which they are potential tools for the treatment of numerous humans and animal diseases caused by biological factors.

The results of the above-described study, in which we observed an increase in the level of histatin-5 and β-defensin-2 along with the severity of dental caries, prove that selected antimicrobial peptides may serve as a tool in the prevention and treatment of dental caries especially in children that are at risk of this disease. Furthermore, the overall demand for the use of natural substances cause the increased interesting in the use of antimicrobial peptides. Consequently, there are possibilities to develop new strategies to treat this disease. Antibacterial peptides are the alternatives to conventional antibiotic treatment. Many studies have been performed on hundreds of antimicrobial peptides that can be used for a more targeted approach associated with selective control or elimination of strains causing tooth decay in children.

In addition, antimicrobial peptides properties are much safer for the youngest users. Our studies indicate that antimicrobial peptides such as histatin-5 and β-defensin-2 should be further studied. Their potential use in oral therapy should be also discussed.

Conclusions

This study has shown that there is a relationship between the amount of salivary β-defensin-2 and Histatin-5 and caries advancement (severe and moderate caries). The occurrence of specific bacterial profiles depending on the levels of the determined proteins was noticed. The use of the saliva proteins concentration could have potential applications in the monitoring of oral diseases, such as caries and periodontal diseases.

Abbreviations

AEP: 

acquired enamel pellicle

AMPs: 

antimicrobial peptides

ATP: 

adenosine triphosphate

CCR6: 

C–C chemokine receptor type 6

CFU: 

colony-forming unit

DMF: 

decayed, missing, filled index

DNA: 

deoxyribonucleic acid

ECC: 

early childhood caries

EGF: 

epidermal growth factor

ELISA: 

enzyme-linked immunosorbent assays

ERK: 

extracellular-signal-regulated kinase

HAdV: 

human adenowirus

HBD: 

human β-defensin

HIV-1: 

human immunodeficiency virus type 1

HLR-S: 

modified medium of Ritz

HNP: 

human neutrophil peptide

HST: 

histatin

HSV-1: 

herpes simplex virus type 1

ICDAS: 

International Caries Detection and Assessment System

IFN-γ: 

interferon γ

IκBα: 

nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor, α

IKK: 

IκB kinase

IL: 

interleukin

JNK: 

c-Jun N-terminal kinase

LBP: 

lipopolysaccharide binding protein

LPO: 

lactoperoxidase

LPS: 

lipopolysaccharide

TLR: 

toll-like receptor

MAPK: 

mitogen-activated protein kinase

MEK: 

mitogen-activated protein kinase

MMP: 

matrix metalloproteinases

NFκB: 

nuclear factor κ-light-chain-enhancer of activated B cells

OD: 

optical density

OPD: 

o-phenyl-enediamine

Raf: 

proto-oncogene serine/threonine-protein kinase

ROS: 

reactive oxygen species

sCD14: 

soluble CD14

sIgA: 

secretory immunoglobulin A

Src: 

proto-oncogene tyrosine-protein kinase Src

TBS: 

tert-butyldimethylsilyl ether

TNF-α: 

tumor necrosis factor α

Declarations

Authors’ contributions

AJ is the person behind the idea of the study and participated in its design, prepared and analyzed samples, performed all experiments during the study. WK participated in the study design and carried out the experiment, performed the statistical analysis and data interpretation and was responsible for the manuscript preparation. DK, MP, PV participated in the study design. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Pediatric Dentistry, Institute of Dentistry, Jagiellonian University, Medical College
(2)
Department of Cytobiology, Pharmacy Faculty, Jagiellonian University, Medical College
(3)
Department of Medical Diagnostics, Pharmacy Faculty, Jagiellonian University, Medical College

References

  1. Dawes C, Siqueira W. The salivary proteome: challenges and perspectives. Proteom Clin Appl. 2011;5:575–9.View ArticleGoogle Scholar
  2. Antonelli G, Chiappin S, De Palo EF, Gatti R. Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clin Chim Acta. 2007;383(1–2):30–40.PubMedGoogle Scholar
  3. Clynes M, Curran A, Dowling P, Henry M, Meleady P, Wormald R. Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis. J Proteom. 2008;71(2):168–75.View ArticleGoogle Scholar
  4. Cabras T, Castagnola M, Calò L, Fanali C, Fiorita A, Iavarone F, Messana I, Paludetti G, Passali GC, Picciotti PM, Pisano E, Scarano E. Potential applications of human saliva as diagnostic fluid. Acta Otorhinolaryngol Ital. 2011;31(6):347–57.PubMed CentralPubMedGoogle Scholar
  5. Lakshmaiah Narayana J, Chen J-Y. Antimicrobial peptides: possible anti-infective agents. Pepitides. 2015. (in press).
  6. Shiomi K, Nakazato M, Ihi T, Kanagawa K, Matsuo H, Matsukura S. Establishment of radioimmunoassay for human neutrophil peptides and their increases in plasma and neutrophil in infection. Biochem Biophys Res Common. 1993;195:1336–44.View ArticleGoogle Scholar
  7. Dorland WAN, editor. Dorland’s illustrated medical dictionary. 28th ed. Philadelphia: Saunders; 1994.Google Scholar
  8. Lichtenstein A, Ganz T, Selested ME, Lehrer RI. In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood. 1986;68:1407–10.PubMedGoogle Scholar
  9. Lichtenstein A, Ganz T, Nguyen TM, Selsted ME, Lehrer RI. Mechanism of target cytolysis by peptide defensins: target cell; metabolic activity, possible endocytosis, are crucial for expression of cytotoxity. J Immunol. 1988;140:2686–94.PubMedGoogle Scholar
  10. Lichtenstein A. Mechanism of mammalian cell lysis mediated by peptide defensins. Evidence for an initial alteration of the plasma membrane. J Clin Invest. 1991;88:93–100.PubMed CentralView ArticlePubMedGoogle Scholar
  11. Muller CA, Markovic-Lipkovski J, Klatt T, Gamper J, Schwarz G, Beck H, Deeg M, Kalbacher H, Widmann S, Wessels TJ, Becker V, Muller GA, Flad T. Human α-defensins HNPs-1, -2 and -3 in renal cell carcinoma. Am J Pathol. 2002;160:1311–24.PubMed CentralView ArticlePubMedGoogle Scholar
  12. Yang D, Chetrov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schroeder JM, Wang JM, Howard OMZ, Oppenheim JJ. Beta-Defensin: linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 1999;286:525–8.View ArticlePubMedGoogle Scholar
  13. Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW, Dale BA. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathway and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun. 2000;68:2907–15.PubMed CentralView ArticlePubMedGoogle Scholar
  14. Moon SK, Lee HY, Li JD, Nagura M, Kang SH, Chun YM, Linthicum FH, Ganz T, Anadalibi A, Lim DJ. Activation of a Src-dependent Raf-MEK 1/2-ERK signaling pathway is required for IL-1 alpha-induced up regulation of beta-defensin 2 in human middle ear epithelial cells. Biochem Biophys Acta. 2002;1590:41–51.View ArticlePubMedGoogle Scholar
  15. Tsutsumi-Ishii Y, Nagaoka I. NF-kappa B-mediated transcriptional regulation of human beta-defensin-2 gene following lipopoly saccharide stimulation. J Leukoc Biol. 2002;71:154–62.PubMedGoogle Scholar
  16. Cirioni O, Giacometti A, Ghiselli R, Orlando F, Kamysz W, D’Amato G, Mocchegiani F, Lukasiak J, Silvestri C, Saba V, Scalise G. Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. J Infect Dis. 2004;190(2):356–64.View ArticlePubMedGoogle Scholar
  17. Pasupuleti M, Schmidtchen A, Malmsten M. Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol. 2012;32(2):143–71.View ArticlePubMedGoogle Scholar
  18. Melino S, Santone C, Di Nardo P, Sarkar B. Histatins: salivary peptides with copper (II) and zinc(II)-binding motifs. Perspectives for biomedical applications. FEBS J. 2014;281:657–72.View ArticlePubMedGoogle Scholar
  19. Groot F, Sanders RW, ter Brake O, Nazmi K, Veerman EC, Bolscher JG, Berkhout B. Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry. J Virol. 2006;80:9236–43.PubMed CentralView ArticlePubMedGoogle Scholar
  20. Wang G. Human antimicrobial peptides and proteins. Pharmaceuticals. 2014;7:545–94.PubMed CentralView ArticlePubMedGoogle Scholar
  21. Kato T, Takahashi N, Kuramitsu HK. Sequence analysis and characterization of the Porphyromonas gingivalis prtC gene, which expresses a novel collagenase activity. Bacteriology. 1992;174:3889–95.Google Scholar
  22. Brand HS, Veerman EC. Saliva and wound healing. Chin J Dent Res. 2013;16:7–12.PubMedGoogle Scholar
  23. Vylkova S, Jang WS, Li W, Nayyar N, Edgerton M. Histatin 5 initiates osmotic stress response in Candida albicans via activation of the Hog1 mitogen-activated protein kinase pathway. Eukaryot Cell. 2007;6(10):1876–88.PubMed CentralView ArticlePubMedGoogle Scholar
  24. Helmerhorst EJ, Troxler RF, Oppenheim FG. The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc Natl Acad Sci USA. 2001;98(25):14637–42.PubMed CentralView ArticlePubMedGoogle Scholar
  25. Sugiyama K, Suzuki Y, Furuta H. Isolation and characterization of histamine-releasing peptides from human parotid saliva. Life Sci. 1985;37:475–80.View ArticlePubMedGoogle Scholar
  26. Wan AK, Seow WK, Walsh LJ, Bird PS. Comparison of five selective media for the growth and enumeration of Streptococcus mutans. Aust Dent J. 2002;47(1):21–6.View ArticlePubMedGoogle Scholar
  27. Sadatullah S, Mohamed NH, Razak FA. The antimicrobial effect of 0.1 ppm ozonated water on 24-hour plaque microorganisms in situ. Braz Oral Res. 2012;26(2):126–31.View ArticlePubMedGoogle Scholar
  28. Krzyściak W, Pluskwa KK, Piątkowski J, Krzyściak P, Jurczak A, Kościelniak D, Skalniak A. The usefulness of biotyping in the determination of selected pathogenicity determinants in Streptococcus mutans. BMC Microbiol. 2014;14:194. doi:10.1186/1471-2180-14-194.PubMed CentralView ArticlePubMedGoogle Scholar
  29. Sugimoto J, Kanehira T, Mizugai H, Chiba I, Morita M. Relationship between salivary histatin 5 levels and Candida CFU counts in healthy elderly. Gerodontology. 2006;23(3):164–9.View ArticlePubMedGoogle Scholar
  30. Selwitz RH, Ismail AI, Pitts NB. Dental caries. Lancet. 2007;369:51–9.View ArticlePubMedGoogle Scholar
  31. Loesche WJ. Role of Streptococcus mutans in human dental decay. Microbiol Rev. 1986;50:353–80.PubMed CentralPubMedGoogle Scholar
  32. Ahn SJ, Ahn SJ, Wen ZT, Brady LJ, Burne RA. Characteristics of biofilm formation by Streptococcus mutans in the presence of saliva. Infect Immun. 2008;6(9):4259–68.View ArticleGoogle Scholar
  33. Zijnge V, van Leeuwen MBM, Degener JE, Abbas F, Thurnheer T, Gmur R, Harsmen HJM. Oral biofilm architecture on natural teeth. PLoS One. 2010;5(2):e9321.PubMed CentralView ArticlePubMedGoogle Scholar
  34. Bowen WH, Koo H. Biology of Streptococcus mutans-derived glucosyltransferases: role in extracellular rmatrix formation of cariogenic biofilms. Caries Res. 2011;45(1):69–86.PubMed CentralView ArticlePubMedGoogle Scholar
  35. Kang MS, Oh JS, Lee HC, Lim HS, Lee SW, Yang KH, Choi NK, Kim SM. Inhibitory effect of Lactobacillus reuteri on periodontopathic and cariogenic bacteria. J Microbiol. 2011;49(2):193–9.View ArticlePubMedGoogle Scholar
  36. Peterson SN, Snesrud E, Schork NJ, Bretz WA. Dental caries pathogenicity: a genomic and metagenomic perspective. Int Dent J. 2011;61(1):11–22.PubMed CentralView ArticlePubMedGoogle Scholar
  37. Wang W, Tao R, Tong Z, Ding Y, Kuang R, Zhai S, Liu J, Ni L. Effect of a novel antimicrobial peptide chrysophsin-1 on oral pathogens and Streptococcus mutans biofilms. Peptides. 2012;33(2):212–9.View ArticlePubMedGoogle Scholar
  38. Gornowicz A, Tokajuk G, Bielawska A, Maciorkowska E, Jabłoński R, Wójcicka A, Bielawski K. The assessment of sIgA, histatin-5, and lactoperoxidase levels in saliva of adolescents with dental caries. Med Sci Monit. 2014;29(20):1095–100.Google Scholar
  39. Pepperney A, Chikindas ML. Antibacterial peptides: opportunities for the prevention and treatment of dental caries. Probiotics Antimicrob Proteins. 2011;3(2):68–96.View ArticleGoogle Scholar
  40. Huo L, Zhang K, Ling J, Peng Z, Huang X, Liu H, Gu L. Antimicrobial and DNA-binding activities of the peptide fragments of human lactoferrin and histatin 5 against Streptococcus mutans. Arch Oral Biol. 2011;56(9):869–76.View ArticlePubMedGoogle Scholar
  41. Van’t Hof W, Reijnders IM, Helmerhorst EJ, Walgreen-Weterings E, Simoons-Smit IM, Veerman EC, Amerongen AV. Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity. Antonie Van Leeuwenhoek. 2000;78:163–9.View ArticlePubMedGoogle Scholar
  42. Nikawa H, Jin C, Fukushima H, Makihira S, Hamada T. Antifungal activity of histatin-5 against non-albicans Candida species. Oral Microbiol Immunol. 2001;16:250–2.View ArticlePubMedGoogle Scholar
  43. Dale BA, Krisanaprakornkit S. Defensin antimicrobial peptides in the oral cavity. J Oral Pathol Med. 2001;30:321–7.View ArticlePubMedGoogle Scholar
  44. Ribeiro TR, Dria KJ, de Carvalho CB, Monteiro AJ, Fonteles MC, de Moraes Carvalho K, Fonteles CS. Salivary peptide profile and its association with early childhood caries. Int J Paediatr Dent. 2013;23(3):225–34.View ArticlePubMedGoogle Scholar
  45. Tao R, Jurevic RJ, Coulton KK, Tsutsui MT, Roberts MC, Kimball JR, Wells N, Berndt J, Dale BA. Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrob Agents Chemother. 2005;49(9):3883–8.PubMed CentralView ArticlePubMedGoogle Scholar
  46. Phattarataratip E, Olson B, Broffitt B, Qian F, Brogden KA, Drake DR, Levy SM, Banas JA. Streptococcus mutans strains recovered from caries-active or caries-free individuals differ in sensitivity to host antimicrobial peptides. Mol Oral Microbiol. 2011;26(3):187–99.PubMed CentralView ArticlePubMedGoogle Scholar
  47. Nishimura E, Eto A, Kato M, Hashizume S, Imai S, Nisizawa T, Hanada N. Oral streptococci exhibit diverse susceptibility to human beta-defensin-2: antimicrobial effects of hBD-2 on oral streptococci. Curr Microbiol. 2004;48(2):85–7.View ArticlePubMedGoogle Scholar
  48. Ouhara K, Komatsuzawa H, Yamada S, Shiba H, Fujiwara T, Ohara M, Sayama K, Hashimoto K, Kurihara H, Sugai M. Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, beta-defensins and LL37, produced by human epithelial cells. J Antimicrob Chemother. 2005;55(6):888–96.View ArticlePubMedGoogle Scholar
  49. Ling Z, Kong J, Jia P, Wei C, Wang Y, Pan Z, Huang W, Li L, Chen H, Xiang C. Analysis of oral microbiota in children with dental caries by PCR-DGGE and barcoded pyrosequencing. Microb Ecol. 2010;60:677–90. doi:10.1007/s00248-010-9712-8.View ArticlePubMedGoogle Scholar
  50. Tanner AC, Mathney JM, Kent RL, Chalmers NI, Hughes CV, Loo CY, Pradhan N, Kanasi E, Hwang J, Dahlan MA, Papadopolou E, Dewhirst FE. Cultivable anaerobic microbiota of severe early childhood caries. J Clin Microbiol. 2011;49(4):1464–74.PubMed CentralView ArticlePubMedGoogle Scholar
  51. Aas JA, Griffen AL, Dardis SR, Lee AM, Olsen I, Dewhirst FE, Leys EJ, Paster BJ. Bacteria of dental caries in primary and permanent teeth in children and young adults. J Clin Microbiol. 2008;46(4):1407–17.PubMed CentralView ArticlePubMedGoogle Scholar
  52. Van Houte J, Lopman J, Kent R. The predominant cultivable flora of sound and carious human root surfaces. J Dent Res. 1994;73(11):1727–34.PubMedGoogle Scholar
  53. Van Houte J, Sansone C, Joshipura K, Kent R. Mutans streptococci and non-mutans streptococci acidogenic at low pH, and in vitro acidogenic potential of dental plaque in two different areas of the human dentition. J Dent Res. 1991;70:1503–7.View ArticlePubMedGoogle Scholar
  54. Gross EL, Beall CJ, Kutsch SR, Firestone ND, Leys EJ, Griffen AL. Beyond Streptococcus mutans: dental caries onset linked to multiple species by 16S rRNA community analysis. PLoS One. 2012;7(10):e47722.PubMed CentralView ArticlePubMedGoogle Scholar
  55. Sampaio-Maia B, Monteiro-Silva F. Acquisition and maturation of oral microbiome throughout childhood: an update. Dent Res J (Isfahan). 2014;11(3):291–301.Google Scholar
  56. Crielaard W, Zaura E, Schuller AA, Huse SM, Montijn RC, Keijser BJ. Exploring the oral microbiota of children at various developmental stages of their dentition in the relation to their oral health. BMC Med Genom. 2011;4:22. doi:10.1186/1755-8794-4-22.View ArticleGoogle Scholar

Copyright

© Jurczak et al. 2015